Literature DB >> 15200409

Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice.

Min Peng1, Leonard Jarett, Ray Meade, Michael P Madaio, Wayne W Hancock, Alfred L George, Eric G Neilson, David L Gasser.   

Abstract

BACKGROUND: Mice that are homozygous for the kidney disease (kd) mutation are apparently healthy for the first 8 weeks of life, but spontaneously develop a severe form of interstitial nephritis that progresses to end-stage renal disease (ESRD) by 4 to 8 months of age. By testing for linkage to microsatellite markers, we previously localized the kd gene to a YAC/BAC contig.
METHODS: The sequence of the entire critical region was examined, and candidate genes were identified. These candidate genes were sequenced in both mutant (kd/kd) mice and normal controls. The phenotype was further characterized by immunohistochemistry and electron microscopy. Transgenic mice were constructed that carried the wild-type allele of the prime candidate gene, and this transgene was transferred to a kd/kd background by breeding.
RESULTS: We have obtained evidence that kd is a mutant allele of a novel gene for a prenyltransferase-like mitochondrial protein (PLMP). This gene is alternatively spliced, with the larger gene product having one domain that resembles transprenyltransferase and another that is similar to geranylgeranyl pyrophosphate synthase. The smaller gene product includes only the first domain. An antiserum to PLMP localizes to mitochondria, and ultrastructural defects are present in the mitochondria of renal tubular epithelial cells, and to a lesser extent, hepatocytes and heart cells from kd/kd mice. In a line of kd/kd mice that carried the wild-type PLMP allele as a transgene, only 1 out of 13 animals expressed the disease by 120 days of age.
CONCLUSION: The kd allele codes for a novel protein that localizes to the mitochondria, and the kd/kd mouse has dysmorphic mitochondria in the renal tubular epithelial cells. This mouse is therefore a unique animal model for studying mechanisms that lead to tubulointerstitial nephritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200409      PMCID: PMC2254219          DOI: 10.1111/j.1523-1755.2004.00702.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

Review 1.  The role of phosphatidylserine in recognition of apoptotic cells by phagocytes.

Authors:  V A Fadok; D L Bratton; S C Frasch; M L Warner; P M Henson
Journal:  Cell Death Differ       Date:  1998-07       Impact factor: 15.828

2.  Identification of a new gene locus for adolescent nephronophthisis, on chromosome 3q22 in a large Venezuelan pedigree.

Authors:  H Omran; C Fernandez; M Jung; K Häffner; B Fargier; A Villaquiran; R Waldherr; N Gretz; M Brandis; F Rüschendorf; A Reis; F Hildebrandt
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1.

Authors:  F Hildebrandt; E Otto; C Rensing; H G Nothwang; M Vollmer; J Adolphs; H Hanusch; M Brandis
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

4.  Characterisation of cellular infiltration and adhesion molecule expression in CBA/CaH-kdkd mice with tubulointerstitial renal disease.

Authors:  V Sibalic; X Fan; R P Wüthrich
Journal:  Histochem Cell Biol       Date:  1997-09       Impact factor: 4.304

5.  An inherited kidney disease of mice resembling human nephronophthisis.

Authors:  M F Lyon; E V Hulse
Journal:  J Med Genet       Date:  1971-03       Impact factor: 6.318

6.  Localization of the mouse kidney disease (kd) gene to a YAC/BAC contig on Chromosome 10.

Authors:  K M Dell; Y X Li; M Peng; E G Neilson; D L Gasser
Journal:  Mamm Genome       Date:  2000-11       Impact factor: 2.957

7.  Regional loss of the mitochondrial membrane potential in the hepatocyte is rapidly followed by externalization of phosphatidylserines at that specific site during apoptosis.

Authors:  W Marty Blom; Hans J G M de Bont; J Fred Nagelkerke
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

8.  A Bedouin kindred with infantile nephronophthisis demonstrates linkage to chromosome 9 by homozygosity mapping.

Authors:  N B Haider; R Carmi; H Shalev; V C Sheffield; D Landau
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

9.  A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution.

Authors:  Edgar Otto; Julia Hoefele; Rainer Ruf; Adelheid M Mueller; Karl S Hiller; Matthias T F Wolf; Maria J Schuermann; Achim Becker; Ralf Birkenhäger; Ralf Sudbrak; Hans C Hennies; Peter Nürnberg; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2002-08-29       Impact factor: 11.025

10.  Cutting Edge: Multiple autoimmune pathways in kd/kd mice.

Authors:  Wayne W Hancock; Tsai-Lung Tsai; Michael P Madaio; David L Gasser
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

View more
  26 in total

1.  Cross-platform expression microarray performance in a mouse model of mitochondrial disease therapy.

Authors:  Zhe Zhang; David L Gasser; Eric F Rappaport; Marni J Falk
Journal:  Mol Genet Metab       Date:  2009-10-30       Impact factor: 4.797

2.  176th ENMC International Workshop: diagnosis and treatment of coenzyme Q₁₀ deficiency.

Authors:  Shamima Rahman; Catherine F Clarke; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2011-07-01       Impact factor: 4.296

3.  An overview of current mouse models recapitulating coenzyme q10 deficiency syndrome.

Authors:  Floriana Licitra; Hélène Puccio
Journal:  Mol Syndromol       Date:  2014-07

4.  Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice.

Authors:  Carly G K Ziegler; Min Peng; Marni J Falk; Erzsebet Polyak; Elpida Tsika; Harry Ischiropoulos; Dana Bakalar; Julie A Blendy; David L Gasser
Journal:  Mitochondrion       Date:  2011-10-01       Impact factor: 4.160

Review 5.  Coenzyme Q and mitochondrial disease.

Authors:  Catarina M Quinzii; Michio Hirano
Journal:  Dev Disabil Res Rev       Date:  2010

6.  Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease.

Authors:  Eriene-Heidi Sidhom; Choah Kim; Maria Kost-Alimova; May Theng Ting; Keith Keller; Julian Avila-Pacheco; Andrew Jb Watts; Katherine A Vernon; Jamie L Marshall; Estefanía Reyes-Bricio; Matthew Racette; Nicolas Wieder; Giulio Kleiner; Elizabeth J Grinkevich; Fei Chen; Astrid Weins; Clary B Clish; Jillian L Shaw; Catarina M Quinzii; Anna Greka
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

7.  The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions.

Authors:  Troy M Hallman; Min Peng; Ray Meade; Wayne W Hancock; Michael P Madaio; David L Gasser
Journal:  J Autoimmun       Date:  2005-12-06       Impact factor: 7.094

8.  Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.

Authors:  Szu-Yuan Li; Jihwan Park; Chengxiang Qiu; Seung Hyeok Han; Matthew B Palmer; Zoltan Arany; Katalin Susztak
Journal:  JCI Insight       Date:  2017-07-20

9.  Tissue-specific oxidative stress and loss of mitochondria in CoQ-deficient Pdss2 mutant mice.

Authors:  Catarina M Quinzii; Caterina Garone; Valentina Emmanuele; Saba Tadesse; Sindu Krishna; Beatriz Dorado; Michio Hirano
Journal:  FASEB J       Date:  2012-11-12       Impact factor: 5.191

10.  Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2.

Authors:  Ryoichi Saiki; Adam L Lunceford; Yuchen Shi; Beth Marbois; Rhonda King; Justin Pachuski; Makoto Kawamukai; David L Gasser; Catherine F Clarke
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.